Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR1 | P21453 | 17/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | IP6K1 | Q92551 | 1/20 | 0.41 |
| ▸ | IP6K3 | Q96PC2 | 1/20 | 0.41 |
| ▸ | IP6K2 | Q9UHH9 | 1/20 | 0.41 |
| ▸ | S1PR3 | Q99500 | 10/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.35 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16400797 | 0.92 | CYP1A2 (0.48) | S1PR1CYP1A2CYP2D6IP6K1IP6K3 | |
| SCHEMBL16409669 | 0.90 | CYP1A2 (0.44) | S1PR1CYP1A2CYP2D6IP6K1IP6K3 | |
| SCHEMBL16401663 | 0.89 | IP6K1 (0.43) | S1PR1CYP1A2CYP2D6IP6K1IP6K3 | |
| SCHEMBL16400700 | 0.84 | CYP1A2 (0.45) | S1PR1CYP1A2CYP2D6IP6K1IP6K3 | |
| SCHEMBL19315816 | 0.83 | S1PR1 (0.38) | S1PR1CYP1A2CYP2D6IP6K1IP6K3 | |
| SCHEMBL16400173 | 0.81 | CYP1A2 (0.48) | S1PR1CYP1A2CYP2D6IP6K1IP6K3 | |
| SCHEMBL1814428 | 0.79 | S1PR1 (0.68) | S1PR1IP6K1IP6K3IP6K2S1PR3 | |
| SCHEMBL1811502 | 0.78 | S1PR1 (0.58) | S1PR1S1PR3CYP3A4CYP2C8KCNH2 | |
| SCHEMBL19315819 | 0.78 | S1PR1 (0.36) | S1PR1CYP1A2CYP2D6IP6K1IP6K3 | |
| SCHEMBL1815710 | 0.77 | S1PR1 (0.61) | S1PR1CYP1A2CYP2D6S1PR3CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3022185-B1 | PESTICIDE COMPOUNDS | BASF SE (DE) | 2017-09-06 | — | — | EP | disclosed |
| US-9497970-B2 | Pesticide compounds | BASF SE (DE) | 2016-11-22 | — | — | US | disclosed |
| US-20160157491-A1 | Pesticide Compounds | BASF SE (DE) | 2016-06-09 | — | — | US | disclosed |
| EP-3022185-A1 | PESTICIDE COMPOUNDS | BASF SE (DE) | 2016-05-25 | — | — | EP | disclosed |
| WO-2015007682-A1 | PESTICIDE COMPOUNDS | BASF SE (DE) | 2015-01-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160157491-A1 | Pesticide Compounds | C1R, C1S, CBR3 | S1PR1 903/4885CYP1A2 371/4885CYP2D6 1489/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.